Natalia Blanco

Company: Morphic Therapeutics

Job title: Associate Director - Immuno-Oncology Biology


Discussion Panel: Debating the Promise of Combinational Strategies with TGF-β 1:00 pm

Read more

day: Day Two

Combining TGF-β with Checkpoint Inhibitors to Increase Efficacy as an Immuno-Oncology Therapeutic 9:30 am

Understanding the rationale for this combination by exploring biomarker dataRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.